What alternative contraceptive medication can be used for a patient who experienced breakthrough bleeding on Nexstellis (estradiol and segesterone acetate) and weight gain on Levlen (levonorgestrel and ethinyl estradiol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Contraceptive Options After Breakthrough Bleeding and Weight Gain

For a patient who experienced breakthrough bleeding on Nexstellis (estradiol and segesterone acetate) and weight gain on Levlen (levonorgestrel and ethinyl estradiol), a copper intrauterine device (Cu-IUD) is the most appropriate alternative contraceptive option.

Understanding the Patient's Issues

The patient has experienced:

  • Breakthrough bleeding with Nexstellis (estradiol and segesterone acetate)
  • Weight gain with Levlen (levonorgestrel and ethinyl estradiol)

These side effects are significant enough to warrant a change in contraceptive method.

Recommended Alternative Options (In Order of Preference)

1. Copper Intrauterine Device (Cu-IUD)

  • Efficacy: Extremely high with typical failure rate of only 0.8% 1
  • Advantages:
    • Hormone-free, eliminating concerns about weight gain
    • Long-acting (up to 10 years)
    • No systemic hormonal side effects
    • No impact on weight 2
    • Does not require daily adherence
  • Considerations: May cause heavier menstrual bleeding initially, but this typically improves over time

2. Levonorgestrel Intrauterine System (LNG-IUD)

  • Efficacy: Extremely high with typical failure rate of 0.1-0.2% 3, 1
  • Advantages:
    • Local hormone delivery with minimal systemic absorption
    • Often reduces menstrual bleeding over time 4
    • Long-acting (3-7 years depending on the specific product)
    • Lower hormone dose than oral contraceptives
  • Considerations: Contains progestin (though with less systemic effects than oral contraceptives), which may be a concern given the patient's history of weight gain with a progestin-containing pill

3. Progestin-Only Pills with Different Progestin Type

  • Efficacy: Typical failure rate of 5-9% 3, 1
  • Advantages:
    • Different progestins have variable androgenic/anti-androgenic profiles 2
    • Norethindrone-based POPs may have different side effect profiles than levonorgestrel-based pills
  • Considerations:
    • POPs have a higher incidence of breakthrough bleeding (up to 40%) 5
    • Breakthrough bleeding is the most common reason for discontinuation in up to 25% of users 6

4. Extended or Continuous Cycle Combined Hormonal Contraceptives

  • Efficacy: Typical failure rate of 5-9% 1
  • Advantages:
    • May reduce breakthrough bleeding compared to traditional cycling 7
    • Different estrogen/progestin combinations may avoid previous side effects
  • Considerations:
    • Risk of weight gain may still exist with other combined hormonal contraceptives
    • Requires careful monitoring of blood pressure 2

Management Algorithm

  1. First-line recommendation: Copper IUD

    • Completely hormone-free
    • Eliminates concerns about weight gain and breakthrough bleeding related to hormonal methods
    • Highly effective (0.8% failure rate)
  2. If patient declines Cu-IUD or has contraindications:

    • Consider LNG-IUD (Kyleena, Mirena, etc.)
    • Local hormone delivery minimizes systemic effects
    • Often reduces menstrual bleeding over time
  3. If IUDs are declined or contraindicated:

    • Consider a progestin-only pill with a different progestin type than previously used
    • Monitor closely for breakthrough bleeding
  4. If all above options are declined or contraindicated:

    • Consider barrier methods (male condoms: 14% typical failure rate) 3
    • Can be combined with fertility awareness methods for increased effectiveness

Important Considerations

  • Blood pressure monitoring: Required before initiating any combined hormonal contraceptives 2
  • Follow-up: Recommended in 4-6 weeks if bleeding persists despite treatment 3
  • Monitoring: Check for mood changes after initiating new contraception, particularly during the first 1-3 months 3
  • Counseling: Inform patient that hormonal contraceptive use does not increase the risk of future infertility 3

Common Pitfalls to Avoid

  1. Assuming all combined hormonal contraceptives will cause the same side effects: Different progestins have variable androgenic/anti-androgenic profiles and estrogen doses vary considerably 2

  2. Overlooking non-hormonal options: The copper IUD is highly effective and eliminates concerns about hormonal side effects

  3. Focusing only on contraceptive efficacy: Patient tolerability and side effect profile are crucial for long-term adherence and satisfaction

  4. Inadequate follow-up: Close monitoring after initiating a new method is essential to address any emerging side effects promptly

The copper IUD represents the best balance of high efficacy and avoidance of the side effects this patient has previously experienced, making it the most appropriate recommendation.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Abnormal Uterine Bleeding Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Risk of Breakthrough Bleeding Justifies the Use of Combined Hormonal Contraception Over Progesterone-Only Pills While Breastfeeding.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2023

Research

Progestogen-only pills and bleeding disturbances.

Human reproduction (Oxford, England), 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.